| CFH, rs1061170 |  | |
---|---|---|---|
Complement proteins, mean (SD) | CC/CT (high risk), n = 82 | TT (low risk), n = 18 | P value |
 C3 [µg/ml] | 876 (398) | 800 (243) | 0.58 |
 C3a [ng/ml] | 573 (251) | 435 (111) | 0.0072 |
 C5a [ng/ml] | 27.09 (11.07) | 26.10 (14.65) | 0.60 |
 C3a/C3-ratio [%] | 0.074 (0.037) | 0.058 (0.018) | 0.011 |
Complement regulatory proteins, mean (SD) | Â | Â | Â |
 CD35 + CD4 + T cells [%] | 4.47 (1.83) | 3.60 (1.05) | 0.071 |
 CD35 + CD8 + T cells [%] | 6.75 (2.98) | 4.96 (3.58) | 0.024 |
 CD35 + Monocytes [%] | 24.26 (3.82) | 25.60 (4.15) | 0.27 |
 CD35 + Classical monocytes [%] | 26.54 (4.47) | 29.41 (5.32) | 0.077 |
 CD35 + Intermediate monocytes [%] | 22.01 (9.04) | 19.16 (6.78) | 0.28 |
 CD35 + Non-classical monocytes [%] | 9.74 (8.26) | 6.67 (4.28) | 0.27 |
 CD46 + CD4 + T cells [%] | 96.94 (2.00) | 97.19 (1.72) | 0.61 |
 CD46 + CD8 + T cells [%] | 98.82 (2.30) | 98.43 (2.68) | 0.60 |
 CD46 + Monocytes [%] | 99.12 (0.96) | 99.01 (0.53) | 0.52 |
 CD46 + Classical monocytes [%] | 99.76 (0.26) | 99.54 (0.38) | 0.043 |
 CD46 + Intermediate monocytes [%] | 99.87 (0.26) | 99.49 (0.70) | 0.050 |
 CD46 + Non-classical monocytes [%] | 92.21 (9.03) | 94.76 (3.20) | 0.043 |
 CD59 + CD4 + T cells [%] | 92.70 (5.34) | 91.99 (7.15) | 0.68 |
 CD59 + CD8 + T cells [%] | 67.05 (8.76) | 71.10 (10.27) | 0.16 |
 CD59 + Monocytes [%] | 48.09 (5.29) | 48.77 (1.85) | 0.27 |
 CD59 + Classical monocytes [%] | 51.12 (2.53) | 51.43 (2.12) | 0.59 |
 CD59 + Intermediate monocytes [%] | 26.95 (17.91) | 26.19 (16.65) | 0.98 |
 CD59 + Non-classical monocytes [%] | 45.92 (14.43) | 48.46 (14.47) | 0.28 |
 CD11b + Monocytes [%] | 98.04 (0.68) | 97.81 (0.94) | 0.36 |
 CD11b + Classical monocytes [%] | 97.63 (0.84) | 97.31 (1.26) | 0.33 |
 CD11b + Intermediate monocytes [%] | 99.69 (0.48) | 99.84 (0.25) | 0.065 |
 CD11b + Non-classical monocytes [%] | 99.83 (0.24) | 99.88 (0.14) | 0.19 |